To hear about similar clinical trials, please enter your email below
Trial Title:
Comparing Breast Magnetic Resonance Imaging (MRI) and Contrast-enhanced Mammography (CEM)
NCT ID:
NCT06008301
Condition:
Breast Cancer Female
Conditions: Official terms:
Breast Neoplasms
Conditions: Keywords:
Contrast enhanced mammography (CEM)
Breast MRI
Financial costs
Time costs
State-trait anxiety inventory (STAI)
Study type:
Interventional
Study phase:
N/A
Overall status:
Not yet recruiting
Study design:
Allocation:
Non-Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Health Services Research
Masking:
None (Open Label)
Intervention:
Intervention type:
Other
Intervention name:
State-Trait Anxiety Inventory (STAI)
Description:
The State-Trait Anxiety Inventory (STAI) has 20 items for assessing trait anxiety and 20
for state anxiety.
Arm group label:
Consent for the entire study
Arm group label:
Consent only for the STAI
Summary:
The investigators will study the financial, time, and psychologic benefit of Contrast
Enhanced Mammography (CEM) compared with Magnetic Resonance Imaging (MRI) for breast
cancer evaluation and ultimately encourage practices and referring providers to use it
more routinely in practice.
Specific research objectives are to:
- determine financial costs of performing a CEM to breast MRI
- compare time costs involved with CEM to breast MRI
- compare psychologic costs involved with CEM to breast MRI.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Age > or equal to 30 years
- Clinically eligible for CEM or breast MRI
- Newly diagnosed cancer
Exclusion Criteria:
- Pregnant as verified by patient report. Given that this test is being performed for
clinical purposes, the determination of pregnancy status will be resolved via the
standard clinical pathway.
Gender:
Female
Minimum age:
30 Years
Maximum age:
N/A
Healthy volunteers:
No
Start date:
December 2024
Completion date:
December 2026
Lead sponsor:
Agency:
Boston Medical Center
Agency class:
Other
Collaborator:
Agency:
Breast Cancer Alliance
Agency class:
Other
Source:
Boston Medical Center
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06008301